Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Outpatient Thrombosis Prevention Trial A Multi-center Adaptive Randomized Placebo-controlled Platform Trial Evaluating the Efficacy and Safety of Anti-thrombotic Strategies in COVID Adults Not Requiring Hospitalization at Time of Diagnosis

NCT04498273 is registered in ClinicalTrials.gov with Frank C Sciurba as lead sponsor.

NCT NCT04498273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04498273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Outpatient Thrombosis Prevention Trial A Multi-center Adaptive Randomized Placebo-controlled Platform Trial Evaluating the Efficacy and Safety of Anti-thrombotic Strategies in COVID Adults Not Requiring Hospitalization at Time of Diagnosis
Lead sponsor
Frank C Sciurba
Phase
Phase 3
Overall status
Terminated
Start date
September 7, 2020
Completion date
August 5, 2021
Enrollment
657 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19